Altimmune, Inc. financial statements
Altimmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 41K | 10-K |
| Net income | −USD 88.09M | 10-K |
| Cash and equivalents | USD 43.76M | 10-Q |
| Total debt | USD 34.29M | 10-Q |